KLF2 and kidney disorder: The expression of KLF2 in ECs confers endothelial integrity by regulating anti-inflammatory and antithrombotic effects (21), while reduced transcriptional activity of KLF2 exacerbates chronic inflammation and endothelial damage in renal diseases (39).